好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Efficacy and Safety of Lamotrigine Extended-Release Adjunctive Therapy in Subjects with Partial Seizures: A Randomized, Double-Blind, Placebo-Controlled Study (ARMOR Study)
Epilepsy
(-)
060
Authors/Disclosures
Dean K. Naritoku, MD, FAAN (University of South Alabama) No disclosure on file
No disclosure on file
Shiliang Zhang No disclosure on file
No disclosure on file
John A. Messenheimer, Jr., MD Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care.